Australia
· Delayed Price · Currency is AUD Osteopore Company Description
Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, the United States, Malaysia, Indonesia, Netherlands, South Africa, Thailand, and internationally.
The company commercializes a range of bespoke products to facilitate bone healing across multiple therapeutic areas.
Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material.
It manufactures and trades medical implants. In addition, it sells medical devices; provides technology services; and engages in research and development.
Osteopore Limited was incorporated in 2018 and is headquartered in Perth, Australia.
| Country | Australia |
| Founded | 2018 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| CEO | Yujing Lim |
Contact Details
Address: 191 Street Georges Terrace Perth, 6000 Australia | |
| Phone | 61 2 8072 1400 |
| Website | osteopore.com |
Stock Details
| Ticker Symbol | OSX |
| Exchange | Australian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | AUD |
| ISIN Number | AU0000053324 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Dr. Yujing Lim | Chief Executive Officer, Chief Technology Officer and Executive Director |
| Kei Wei Leong | Executive Chairman |
| Shu Ning Voon | Financial Controller |
| Khoon Seng Goh | Global Marketing Director |
| Jack Rosagro | Company Secretary |